Inventiva S.A
IVA.PA
Exchange: | PA |
Currency | Euro |
ISIN: | FR0013233012 |
Primary Ticker: | IVA.PA |
Fiscal Year End: | December |
Sector: | Healthcare |
Industry: | Biotechnology |
Gic Sector: | Health Care |
Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
Gic Industry: | Biotechnology |
Gic Sub Industry: | Biotechnology |
Description: | Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France. |
Address: | 50 rue de Dijon, Daix, France, 21121 |
Website: | https://www.inventivapharma.com |
Full Time Employees: | 123 |
Updated On: | 2024-11-03 |
Highlights
Market Capitalization: | 216124416 |
Market Capitalization Mln: | 216.12 |
EBITDA: | -98356000 |
Wall Street Target Price: | 14 |
Book Value: | -1.50 |
Earnings Share: | -2.06 |
Most Recent Quarter: | 2024-06-30 |
Operating Margin TTM: | -19.11 |
Return On Assets TTM: | -1.13 |
Return On Equity TTM: | -16.42 |
Revenue TTM: | 19275000 |
Revenue Per Share TTM: | 0.38 |
Quarterly Revenue Growth YOY: | -0.58 |
Gross Profit TTM: | 18814000 |
Diluted Eps TTM: | -2.06 |
Valuation
Price Sales TTM: | 11.05 |
Price Book MRQ: | 2.00 |
Enterprise Value: | 172542344 |
Enterprise Value Revenue: | 11.04 |
Enterprise Value Ebitda: | -2.31 |
Shares
Shares Outstanding: | 52361500 |
Shares Float: | 13975200 |
Percent Insiders: | 12.44 |
Percent Institutions: | 53.54 |
Technicals
Beta: | 1.01 |
52 Week High: | 4.44 |
52 Week Low: | 1.43 |
50 Day MA: | 2.06 |
200 Day MA: | 2.77 |
Earnings
Report Date: | 2025-04-18 |
Date: | 2025-03-31 |
Before After Market: | Before Market |
Currency: | EUR |
Report Date: | 2025-03-26 |
Date: | 2024-12-31 |
Before After Market: | After Market |
Currency: | EUR |
Report Date: | 2024-05-21 |
Date: | 2024-03-31 |
Before After Market: | After Market |
Currency: | EUR |
Eps Estimate: | -0.42 |
Eps Difference: | 0.42 |
Surprise Percent: | 10 |
Report Date: | 2023-11-21 |
Date: | 2023-09-30 |
Before After Market: | After Market |
Currency: | EUR |
Eps Actual: | -0.48 |
Eps Estimate: | -0.45 |
Eps Difference: | -0.03 |
Surprise Percent: | -7.63 |
Report Date: | 2023-09-28 |
Date: | 2023-06-30 |
Before After Market: | Before Market |
Currency: | EUR |
Eps Actual: | -1.31 |
Eps Estimate: | -0.73 |
Eps Difference: | -0.58 |
Surprise Percent: | -79.45 |
Report Date: | 2023-05-16 |
Date: | 2023-03-31 |
Before After Market: | After Market |
Currency: | EUR |
Eps Actual: | -0.26 |
Eps Estimate: | -0.20 |
Eps Difference: | -0.05 |
Surprise Percent: | -27.82 |
Report Date: | 2023-03-29 |
Date: | 2022-12-31 |
Before After Market: | After Market |
Currency: | EUR |
Eps Actual: | 0.07 |
Report Date: | 2022-11-10 |
Date: | 2022-09-30 |
Before After Market: | After Market |
Currency: | EUR |
Report Date: | 2022-07-07 |
Date: | 2022-06-30 |
Before After Market: | After Market |
Currency: | EUR |
Eps Actual: | -0.72 |
Report Date: | 2022-05-17 |
Date: | 2022-03-31 |
Currency: | EUR |
Report Date: | 2022-03-07 |
Date: | 2021-12-31 |
Before After Market: | After Market |
Currency: | EUR |
Eps Actual: | -0.67 |
Eps Estimate: | -0.73 |
Eps Difference: | 0.06 |
Surprise Percent: | 8.21 |
Report Date: | 2021-11-10 |
Date: | 2021-09-30 |
Before After Market: | After Market |
Currency: | EUR |
Eps Estimate: | -0.29 |
Eps Difference: | 0.29 |
Surprise Percent: | 10 |
Report Date: | 2021-07-28 |
Date: | 2021-06-30 |
Before After Market: | After Market |
Currency: | EUR |
Eps Actual: | -0.6 |
Eps Estimate: | -0.68 |
Eps Difference: | 0.08 |
Surprise Percent: | 11.76 |
Report Date: | 2021-05-13 |
Date: | 2021-03-31 |
Currency: | EUR |
Eps Estimate: | -0.27 |
Eps Difference: | 0.27 |
Surprise Percent: | 10 |
Report Date: | 2021-03-04 |
Date: | 2020-12-31 |
Before After Market: | After Market |
Currency: | EUR |
Eps Actual: | -0.39 |
Eps Estimate: | -0.68 |
Eps Difference: | 0.29 |
Surprise Percent: | 42.64 |
Report Date: | 2020-11-12 |
Date: | 2020-09-30 |
Before After Market: | After Market |
Currency: | EUR |
Eps Actual: | -0.32 |
Eps Estimate: | -0.32 |
Report Date: | 2020-07-06 |
Date: | 2020-06-30 |
Before After Market: | After Market |
Currency: | EUR |
Eps Actual: | -0.3 |
Eps Estimate: | -0.7 |
Eps Difference: | 0.4 |
Surprise Percent: | 57.14 |
Report Date: | 2020-05-14 |
Date: | 2020-03-31 |
Before After Market: | After Market |
Currency: | EUR |
Eps Actual: | -0.23 |
Report Date: | 2020-03-10 |
Date: | 2019-12-31 |
Before After Market: | After Market |
Currency: | EUR |
Eps Actual: | -0.39 |
Eps Difference: | -0.39 |
Report Date: | 2019-11-13 |
Date: | 2019-09-30 |
Before After Market: | After Market |
Currency: | EUR |
Report Date: | 2019-09-25 |
Date: | 2019-06-30 |
Before After Market: | After Market |
Currency: | EUR |
Eps Actual: | -0.93 |
Eps Difference: | -0.93 |
Report Date: | 2019-05-15 |
Date: | 2019-03-31 |
Before After Market: | After Market |
Currency: | EUR |
Eps Actual: | -0.78 |
Eps Estimate: | -0.78 |
Report Date: | 2018-09-27 |
Date: | 2018-06-30 |
Before After Market: | After Market |
Currency: | EUR |
Eps Actual: | -0.86 |
Eps Difference: | -0.86 |
Report Date: | 2018-05-15 |
Date: | 2018-03-31 |
Before After Market: | After Market |
Currency: | EUR |
Eps Actual: | -0.51 |
Eps Difference: | -0.51 |
Report Date: | 2017-09-26 |
Date: | 2017-06-30 |
Before After Market: | After Market |
Currency: | EUR |
Eps Actual: | -0.6 |
Eps Difference: | -0.6 |
Date: | 2022-12-31 |
Period: | +1y |
Growth: | -0.48 |
Earnings Estimate Year Ago Eps: | -1.28 |
Earnings Estimate Growth: | -0.48 |
Revenue Estimate Avg: | 12179000.00 |
Revenue Estimate Low: | 4900000.00 |
Revenue Estimate High: | 18600000.00 |
Revenue Estimate Number Of Analysts: | 7.00 |
Revenue Estimate Growth: | 1.90 |
Eps Trend7days Ago: | -1.40 |
Eps Trend30days Ago: | -1.40 |
Eps Trend60days Ago: | -1.40 |
Eps Trend90days Ago: | -1.40 |
Eps Revisions Down Last7days: | 1.00 |
Date: | 2022-03-31 |
Period: | +1q |
Revenue Estimate Avg: | 33000.00 |
Revenue Estimate Growth: | -0.15 |
Date: | 2021-12-31 |
Revenue Estimate Avg: | 4194000.00 |
Revenue Estimate Low: | 140000.00 |
Revenue Estimate High: | 9330000.00 |
Revenue Estimate Number Of Analysts: | 5.00 |
Eps Trend7days Ago: | -1.28 |
Eps Trend30days Ago: | -1.28 |
Eps Trend60days Ago: | -1.28 |
Eps Trend90days Ago: | -1.28 |
Date: | 2019-12-31 |
Period: | +1y |
Revenue Estimate Avg: | 5900000.00 |
Revenue Estimate Low: | 2000000.00 |
Revenue Estimate High: | 11000000.00 |
Revenue Estimate Number Of Analysts: | 5.00 |
Revenue Estimate Growth: | 0.20 |
Eps Trend7days Ago: | -1.34 |
Eps Trend30days Ago: | -1.34 |
Eps Trend60days Ago: | -1.34 |
Eps Trend90days Ago: | -1.34 |
Date: | 2019-06-30 |
Period: | +1q |
Revenue Estimate Avg: | 4900000.00 |
Revenue Estimate Low: | 2500000.00 |
Revenue Estimate High: | 9000000.00 |
Revenue Estimate Number Of Analysts: | 5.00 |
Revenue Estimate Growth: | -0.24 |
Date: | 2019-03-31 |
Revenue Estimate Avg: | 4900000.00 |
Revenue Estimate Low: | 2500000.00 |
Revenue Estimate High: | 9000000.00 |
Revenue Estimate Number Of Analysts: | 5.00 |
Revenue Estimate Growth: | -0.24 |
Date: | 2018-12-31 |
Revenue Estimate Avg: | 4900000.00 |
Revenue Estimate Low: | 2500000.00 |
Revenue Estimate High: | 9000000.00 |
Revenue Estimate Number Of Analysts: | 5.00 |
Revenue Estimate Growth: | -0.24 |
Eps Trend7days Ago: | -1.26 |
Eps Trend30days Ago: | -1.26 |
Eps Trend60days Ago: | -1.26 |
Eps Trend90days Ago: | -1.26 |
Date: | 2024-03-31 |
Eps Actual: | -2.06 |
Date: | 2022-12-31 |
Eps Actual: | -0.64 |
Date: | 2021-12-31 |
Eps Actual: | -1.2 |
Date: | 2020-12-31 |
Eps Actual: | -1.2 |
Date: | 2019-12-31 |
Eps Actual: | -4.0 |